Inhibition of multidrug resistance by immunisation with synthetic P-glycoprotein-derived peptides
- 31 March 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (4), 606-613
- https://doi.org/10.1016/j.ejca.2003.11.019
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Immune Response against the Murine MDRI Protein Induced by Vaccination with Synthetic Lipopeptides in LiposomesBiochemical and Biophysical Research Communications, 1995
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P‐glycoproteinInternational Journal of Cancer, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitroCancer Immunology, Immunotherapy, 1992
- In situ neutralization in Boc‐chemistry solid phase peptide synthesisInternational Journal of Peptide and Protein Research, 1992
- Suppression of the Immune Response by a Soluble Complement Receptor of B LymphocytesScience, 1991
- Do Anti-P-Glycoprotein Antibodies Have a Future in the Circumvention of Multidrug Resistance?JNCI Journal of the National Cancer Institute, 1991
- Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II studyCancer, 1990
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963